Drugs that contain Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate
1. Osmoprep patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US7687075 | SALIX PHARMS | Colonic purgative composition with soluble binding agent |
Jun, 2028
(4 years from now) | |
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5616346 | SALIX PHARMS | Non-aqueous colonic purgative formulations |
May, 2013
(10 years ago) | |
Market Authorisation Date: 16 March, 2006
Treatment: For cleansing the bowel in preparation for colonoscopy, in adults 18 years of age or older
Dosage: TABLET;ORAL
How can I launch a generic of OSMOPREP before it's drug patent expiration?
More Information on Dosage
OSMOPREP family patents
2. Visicol patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5616346 | SALIX PHARMS | Non-aqueous colonic purgative formulations |
May, 2013
(10 years ago) | |
Market Authorisation Date: 21 September, 2000
Treatment: Method of use of visicol
Dosage: TABLET;ORAL
More Information on Dosage
VISICOL family patents